Interobserver variability in Gleason histological grading of prostate cancer
Open accessThe DOI matches its Crossref record.
Abstract
OBJECTIVE: The aims of this study were to evaluate the reproducibility of the Gleason grading system and to compare its interobserver variability with the novel Gleason grade grouping proposal using a large sample volume. MATERIALS AND METHODS: In total, 407 pathology slides of prostate needle biopsies from 34 consecutive patients with prostate cancer were re-evaluated. The International Society of Urological Pathology 2005 modified Gleason grading system with Epstein's modification was used. Two pathologists, blind to each other and to the initial pathology report, performed the pathological evaluation. To determine interobserver concordance, the kappa (κ) coefficient test was used. RESULTS: Pathologist 1 and pathologist 2 detected a tumor in 202 and 231 cores, respectively (p < 0.001). The two pathologists disagreed on the presence of a tumor in 31 cores. Of these 31 cores, 74% (n = 23/31) were Gleason pattern 3. The mean length of the cancer foci in these 31 disputed cores was 1.54 ± 0.8 mm. Concordance rates between the two observers for primary and secondary Gleason patterns were 63.96% (κ = 0.34) and 63.45% (κ = 0.37), respectively. Concordance with respect to the Gleason sum was 57.9% (κ = 0.43). When the Gleason scores were classified into the novel Gleason grade grouping, concordance was found to be 51.7% (κ = 0.39). CONCLUSIONS: The agreement between observers on the Gleason sum was moderate. The novel Gleason grade grouping did not improve interobserver agreement. Further studies are needed to confirm these results on interobserver variability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bulten, W., Pinckaers, H., van Boven, H., Vink, R., de Bel, T., van Ginneken, B., van der Laak, J., Hulsbergen-van de Kaa, C., & Litjens, G. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30739-9 · Cited by 705
Ström, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D. M., Bostwick, D. G., Evans, A. J., Grignon, D. J., Humphrey, P. A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30738-7 · Cited by 620
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Bulten, W., Kartasalo, K., Chen, P.-H. C., Ström, P., Pinckaers, H., Nagpal, K., Cai, Y., Steiner, D. F., van Boven, H., Vink, R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01620-2 · Cited by 543
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446
Salvi, M., Acharya, U. R., Molinari, F., & Meiburger, K. M. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104129 · Cited by 386
Metadata
- Authors
- Ozkan, T. A., Eruyar, A. T., Cebeci, O. O., Memik, O., Ozcan, L., & Kuskonmaz, I.
- Venue
- Scandinavian Journal of Urology
- Publisher
- Medical Journals Sweden AB
- Published
- 2016-07-14
- Volume
- 50
- Issue
- 6
- Pages
- 420-424
- ISSN
- 2168-1805 (ISSN-L)
- 2168-1813
- OpenAlex
- W2475054117
- Cited by
- 195
- References
- 0
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interobserver variability in Gleason histological grading of prostate cancer. https://app.cochat.ai/papers/10.1080/21681805.2016.1206619
- The paper
- Ozkan, T. A., Eruyar, A. T., Cebeci, O. O., Memik, O., Ozcan, L., & Kuskonmaz, I. (2016). Interobserver variability in Gleason histological grading of prostate cancer. Scandinavian Journal of Urology. https://doi.org/10.1080/21681805.2016.1206619
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.